| Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens JM Kaplan, Q Yu, ST Piraino, SE Pennington, S Shankara, LA Woodworth, ... The Journal of Immunology 163 (2), 699-707, 1999 | 250 | 1999 |
| Development of a simple and rapid method for producing non‐fucosylated oligomannose containing antibodies with increased effector function Q Zhou, S Shankara, A Roy, H Qiu, S Estes, A McVie‐Wylie, ... Biotechnology and Bioengineering 99 (3), 652-665, 2008 | 240 | 2008 |
| Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis SP Rao, J Sancho, J Campos-Rivera, PM Boutin, PB Severy, T Weeden, ... PloS one 7 (6), e39416, 2012 | 193 | 2012 |
| Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele S Gnjatic, Y Nagata, E Jäger, E Stockert, S Shankara, BL Roberts, ... Proceedings of the National Academy of Sciences 97 (20), 10917-10922, 2000 | 139 | 2000 |
| Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the escherichia coli purine nucleoside phosphorylase gene L Mohr, S Shankara, SK Yoon, TU Krohne, M Geissler, B Roberts, ... Hepatology 31 (3), 606-614, 2000 | 114 | 2000 |
| Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization RG Bagley, N Honma, W Weber, P Boutin, C Rouleau, S Shankara, ... Microvascular research 76 (3), 180-188, 2008 | 104 | 2008 |
| Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro TU Krohne, S Shankara, M Geissler, BL Roberts, JR Wands, HE Blum, ... Hepatology 34 (3), 511-518, 2001 | 99 | 2001 |
| Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function C Rouleau, A Roy, T St. Martin, MR Dufault, P Boutin, D Liu, M Zhang, ... Molecular cancer therapeutics 5 (2), 219-229, 2006 | 90 | 2006 |
| Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration SK Ryan, M Zelic, Y Han, E Teeple, L Chen, M Sadeghi, S Shankara, ... Nature neuroscience 26 (1), 12-26, 2023 | 85 | 2023 |
| Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro E Havari, MJ Turner, J Campos‐Rivera, S Shankara, TH Nguyen, ... Immunology 141 (1), 123-131, 2014 | 84 | 2014 |
| Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models WM Siders, J Shields, C Garron, Y Hu, P Boutin, S Shankara, W Weber, ... Leukemia & lymphoma 51 (7), 1293-1304, 2010 | 82 | 2010 |
| Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1α C Jiang, H Lu, KA Vincent, S Shankara, AJ Belanger, SH Cheng, GY Akita, ... Physiological genomics 8 (1), 23-32, 2002 | 78 | 2002 |
| In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A* 0201-restricted CD8+ T cells in patients with melanoma GP Linette, S Shankara, S Longerich, S Yang, R Doll, C Nicolette, ... The Journal of Immunology 164 (6), 3402-3412, 2000 | 66 | 2000 |
| Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248 RG Bagley, C Rouleau, T St. Martin, P Boutin, W Weber, M Ruzek, ... Molecular cancer therapeutics 7 (8), 2536-2546, 2008 | 65 | 2008 |
| Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R A Nanda, P Buckhaults, S Seaman, N Agrawal, P Boutin, S Shankara, ... Cancer research 64 (23), 8507-8511, 2004 | 60 | 2004 |
| Characterization of in vitro antimurine thymocyte globulin–induced regulatory T cells that inhibit graft-versus-host disease in vivo MC Ruzek, JS Waire, D Hopkins, G LaCorcia, J Sullivan, BL Roberts, ... Blood, The Journal of the American Society of Hematology 111 (3), 1726-1734, 2008 | 52 | 2008 |
| Induction of c-jun protooncogene expression and transcription factor AP-1 activity by the polyoma virus middle-sized tumor antigen. A Schönthal, S Srinivas, W Eckhart Proceedings of the National Academy of Sciences 89 (11), 4972-4976, 1992 | 49 | 1992 |
| Polyomavirus middle-sized tumor antigen modulates c-Jun phosphorylation and transcriptional activity. S Srinivas, A Schönthal, W Eckhart Proceedings of the National Academy of Sciences 91 (21), 10064-10068, 1994 | 46 | 1994 |
| Pericytes from human non-small cell lung carcinomas: an attractive target for anti-angiogenic therapy RG Bagley, C Rouleau, SD Morgenbesser, W Weber, BP Cook, ... Microvascular research 71 (3), 163-174, 2006 | 38 | 2006 |
| Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens MA Perricone, KA Claussen, KA Smith, JM Kaplan, S Piraino, S Shankara, ... Molecular Therapy 1 (3), 275-284, 2000 | 37 | 2000 |
